Table 3 Progression-free survival Cox regression analysis c-scores for subset of 166 non-squamous carcinoma patients with available mutation status of KRAS and STK11 genes.
Model | Components | Fivefold cross-validated c-score, 95% CI |
|---|---|---|
Clinical model | BMI, smoking status | 0.56, [0.51, 0.59] |
Combination model | Radiomic phenotypes, radiological variables (SUVmax, longest tumor diameter at baseline), pathological variable (PD-L1 expression, KRAS expression, STK11 expression) | 0.6, [0.52, 0.61] |
Combination clinical model | Radiomic phenotypes, radiological variables (SUVmax, longest tumor diameter at baseline), pathological variable (PD-L1 expression, KRAS expression, STK11 expression), BMI, smoking status | 0.64, [0.57,0.68] |
Multiomic graph phenotypes | Multiomic graph phenotypes | 0.62, [0.58, 0.67] |
Multiomic graph clinical model | Multiomic graph phenotypes, BMI, smoking status | 0.68, [0.58, 0.69] |
